Foghorn Therapeutics Inc. (FHTX) Return on equity 2020–2022
Foghorn Therapeutics Inc. (FHTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-97216.1%FY2022 · since FY2020: -47.1% → -97216.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -97216.1% | -97111.5 pp |
| FY2021 | -104.6% | -57.5 pp |
| FY2020 | -47.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice